Annis Gardner Whiting Capital Advisors, LLC Haemonetics Corp Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $279 Billion
- Q1 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 142 shares of HAE stock, worth $11,957. This represents 0.0% of its overall portfolio holdings.
Number of Shares
142Holding current value
$11,957% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HAE
# of Institutions
311Shares Held
50.1MCall Options Held
161KPut Options Held
56.3K-
Capital Research Global Investors Los Angeles, CA6.67MShares$562 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.98MShares$504 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.4MShares$455 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.27MShares$360 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY3.79MShares$319 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.32B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...